Christian G Bien Selected Research

Genetic Predisposition to Disease (Genetic Predisposition)

1/2023	A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
1/2019	Diagnosing autoimmune encephalitis based on clinical features and autoantibody findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian G Bien Research Topics

Disease

40	Epilepsy (Aura) 07/2023 - 08/2002
31	Encephalitis (Encephalitis, Rasmussen) 05/2023 - 03/2008
29	Seizures (Absence Seizure) 01/2023 - 09/2005
18	Autoimmune Diseases of the Nervous System 02/2024 - 01/2013
16	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 07/2023 - 03/2004
14	Glioma (Gliomas) 01/2023 - 08/2012
9	Temporal Lobe Epilepsy 05/2023 - 04/2010
9	Brain Diseases (Brain Disorder) 01/2020 - 03/2004
5	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2023 - 01/2012
5	Neoplasms (Cancer) 01/2019 - 06/2006
4	Hippocampal Sclerosis 01/2023 - 03/2009
4	Ataxia (Dyssynergia) 01/2023 - 01/2016
4	Myoclonus (Nocturnal Myoclonus) 01/2023 - 03/2008
4	Inflammation (Inflammations) 10/2021 - 06/2006
4	Drug Resistant Epilepsy 01/2021 - 03/2013
3	Movement Disorders (Movement Disorder) 01/2023 - 03/2008
3	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2023 - 08/2014
3	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 07/2011
3	Epileptic Syndromes 01/2021 - 04/2011
3	Nervous System Diseases (Neurological Disorders) 02/2020 - 08/2015
3	Partial Epilepsies (Epilepsy, Partial) 11/2016 - 08/2014
3	Epilepsia Partialis Continua 12/2015 - 03/2008
2	Pain (Aches) 02/2024 - 01/2023
2	Ganglioglioma 06/2023 - 01/2023
2	Memory Disorders (Memory Loss) 01/2023 - 02/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023 - 01/2019
2	Tremor (Tremors) 01/2023 - 03/2008
2	Autoimmune limbic encephalitis 01/2022 - 01/2017
2	Paresis (Hemiparesis) 01/2020 - 08/2002
2	Cognitive Dysfunction 01/2018 - 01/2011
2	Focal Cortical Dysplasia 02/2015 - 07/2007
2	Atrophy 05/2012 - 04/2012
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2012 - 03/2008
1	Back Pain (Backache) 02/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2024
1	Diabetes Mellitus 02/2024
1	Chronic Pain 02/2024
1	Aseptic Meningitis 01/2024
1	Viral Meningitis 01/2024
1	Meningitis 01/2024
1	Dyskinesias (Dyskinesia) 07/2023
1	Neuromyelitis Optica (Devic's Disease) 05/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Fatigue 01/2023
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2023
1	Sleep Wake Disorders 01/2023
1	Malformations of Cortical Development 01/2023

Drug/Important Bio-Agent (IBA)

53	AntibodiesIBA 01/2024 - 03/2004
21	AutoantibodiesIBA 02/2024 - 09/2005
20	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2012
19	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 04/2009
17	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2023 - 04/2010
14	Leucine (L-Leucine)FDA Link 01/2023 - 05/2013
11	AntigensIBA 07/2023 - 05/2012
10	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 07/2020 - 03/2004
10	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 08/2009
5	Immunoglobulin G (IgG)IBA 02/2024 - 05/2014
5	Surface Antigens (Surface Antigen)IBA 05/2023 - 05/2011
5	Complement System Proteins (Complement)IBA 01/2018 - 05/2012
4	Aminobutyrates (Aminobutyric Acid)IBA 01/2023 - 03/2016
4	Lacosamide FDA Link 01/2021 - 07/2015
4	N-Methylaspartate (NMDA)IBA 03/2016 - 06/2010
4	Potassium Channels (Potassium Channel)IBA 03/2016 - 03/2004
3	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2023 - 01/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2009
3	trans-sodium crocetinate (crocetin)IBA 01/2021 - 07/2011
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 08/2009
3	Glycine Receptors (Glycine Receptor)IBA 01/2021 - 08/2011
3	AMPA Receptors (AMPA Receptor)IBA 03/2016 - 04/2011
2	anti-CASPR2 autoantibodyIBA 02/2024 - 01/2023
2	Phosphotransferases (Kinase)IBA 06/2023 - 01/2023
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2022
2	Levetiracetam (Keppra)FDA LinkGeneric 06/2022 - 01/2021
2	N 30IBA 01/2021 - 12/2020
2	AcidsIBA 01/2021 - 08/2012
2	Rituximab (Mabthera)FDA Link 01/2021 - 08/2009
2	metabotropic glutamate receptor type 1IBA 12/2020 - 11/2020
2	brivaracetamIBA 01/2020 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 04/2016 - 02/2014
2	TOR Serine-Threonine KinasesIBA 01/2016 - 02/2015
2	erucylphosphocholineIBA 12/2015 - 03/2008
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2013 - 08/2009
2	SteroidsIBA 01/2013 - 03/2008
2	Glutamate Receptors (Glutamate Receptor)IBA 08/2012 - 06/2010
2	GABA-B ReceptorsIBA 08/2012 - 08/2011
2	gamma-Aminobutyric Acid (GABA)IBA 08/2012 - 08/2011
2	Oligoclonal BandsIBA 01/2012 - 06/2010
1	Glial Fibrillary Acidic ProteinIBA 01/2024
1	Myelin-Oligodendrocyte GlycoproteinIBA 05/2023
1	CenobamateIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	NucleotidesIBA 01/2023
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2023
1	Therapeutic UsesIBA 01/2023

Therapy/Procedure

15	Immunotherapy 01/2023 - 03/2004
7	Therapeutics 01/2019 - 01/2013
3	Electrodes (Electrode) 09/2021 - 01/2011
2	Drug Therapy (Chemotherapy) 01/2022 - 08/2002
2	Hemispherectomy 02/2014 - 03/2013
1	Drug Tapering 01/2023